(AIN) Albany International - NYSE
Sector: Consumer Cyclical | Industry: Textile Manufacturing | Exchange: NYSE (USA) | Market Cap: 1.993m USD | Total Return: 6% in 12m
Avg Turnover: 15.2M
EPS Trend: -87.7%
Qual. Beats: 0
Rev. Trend: 46.0%
Qual. Beats: 2
Warnings
High Debt/EBITDA (7.7) with thin interest coverage (-1.4)
Interest Coverage Ratio -1.4 is critical
Tailwinds
Supp Ema20
Albany International Corp. (AIN) is a specialized industrial manufacturer operating through two primary segments: Machine Clothing (MC) and Albany Engineered Composites (AEC). The MC segment produces essential consumable fabrics and belts used in the production of paper, pulp, and nonwovens. The AEC segment focuses on high-performance 3D-woven and injected composite components for commercial and defense aerospace applications, including aircraft engines and airframes.
The company serves as a critical supplier in the aerospace supply chain, where complex composite materials are increasingly favored over traditional metals to reduce weight and improve fuel efficiency. In the paper industry, machine clothing is a recurring replacement part, providing the business with a steady aftermarket revenue stream tied to global paper and packaging production volumes.
Investors can evaluate the company’s valuation and growth metrics further on ValueRay. Founded in 1895 and headquartered in New Hampshire, Albany International maintains a global manufacturing footprint across North America, Europe, Asia, and South America to support its international customer base.
- Commercial aerospace ramp-up drives demand for AEC segment engine and airframe components
- Global paper and packaging production volumes dictate Machine Clothing segment recurring revenue
- Defense spending levels impact long-term composite contracts for military aircraft and space
- Raw material price volatility and energy costs influence manufacturing margins across segments
- Expansion into advanced air mobility markets provides long-term growth catalyst for engineered composites
| Net Income: -59.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -3.05 > 1.0 |
| NWC/Revenue: 43.53% < 20% (prev 46.46%; Δ -2.94% < -1%) |
| CFO/TA 0.09 > 3% & CFO 156.0m > Net Income -59.4m |
| Net Debt (365.7m) to EBITDA (47.5m): 7.71 < 3 |
| Current Ratio: 2.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.6m) vs 12m ago -7.86% < -2% |
| Gross Margin: 20.51% > 18% (prev 32.30%; Δ -11.79% > 0.5%) |
| Asset Turnover: 70.39% > 50% (prev 71.45%; Δ -1.06% > 0%) |
| Interest Coverage Ratio: -1.40 > 6 (EBIT TTM -36.3m / Interest Expense TTM 26.0m) |
| A: 0.30 (Total Current Assets 963.3m - Total Current Liabilities 438.6m) / Total Assets 1.74b |
| B: 0.57 (Retained Earnings 983.7m / Total Assets 1.74b) |
| C: -0.02 (EBIT TTM -36.3m / Avg Total Assets 1.71b) |
| D: 0.73 (Book Value of Equity 729.4m / Total Liabilities 1.00b) |
| Altman-Z'' = 4.45 = AA |
| DSRI: 0.72 (Receivables 322.5m/447.9m, Revenue 1.21b/1.21b) |
| GMI: 1.57 (GM 32.30% / 20.51%) |
| AQI: 0.83 (AQ_t 0.17 / AQ_t-1 0.21) |
| SGI: 1.00 (Revenue 1.21b / 1.21b) |
| TATA: -0.12 (NI -59.4m - CFO 156.0m) / TA 1.74b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of June 19, 2026, the stock is trading at USD 70.37 with a total of 230,177 shares traded.
Over the past week, the price has changed by +4.05%,
over one month by +15.51%,
over three months by +30.55% and
over the past year by +6.00%.
Albany International has received a consensus analysts rating of 3.75. Therefore, it is recommended to hold AIN.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 58.7 | -16.6% |
P/E Forward = 21.645
P/S = 1.6535
P/B = 2.7325
P/EG = 1.443
Revenue TTM = 1.21b USD
EBIT TTM = -36.3m USD
EBITDA TTM = 47.5m USD
Long Term Debt = 476.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 488.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.7m
Net Debt = 365.7m USD (calculated: Debt 488.2m - CCE 122.6m)
Enterprise Value = 2.36b USD (1.99b + Debt 488.2m - CCE 122.6m)
Interest Coverage Ratio = -1.40 (Ebit TTM -36.3m / Interest Expense TTM 26.0m)
EV/FCF = 25.57x (Enterprise Value 2.36b / FCF TTM 92.2m)
FCF Yield = 3.91% (FCF TTM 92.2m / Enterprise Value 2.36b)
FCF Margin = 7.65% (FCF TTM 92.2m / Revenue TTM 1.21b)
Net Margin = -4.93% (Net Income TTM -59.4m / Revenue TTM 1.21b)
Gross Margin = 20.51% ((Revenue TTM 1.21b - Cost of Revenue TTM 958.1m) / Revenue TTM)
Gross Margin QoQ = 32.05% (prev 31.09%)
Tobins Q-Ratio = 1.36 (Enterprise Value 2.36b / Total Assets 1.74b)
Interest Expense / Debt = 5.33% (Interest Expense 26.0m / Debt 488.2m)
Taxrate = 33.12% (7.65m / 23.1m)
NOPAT = -24.3m (EBIT -36.3m * (1 - 33.12%)) [loss with tax shield]
Current Ratio = 2.20 (Total Current Assets 963.3m / Total Current Liabilities 438.6m)
Debt / Equity = 0.67 (Debt 488.2m / totalStockholderEquity, last quarter 729.4m)
Debt / EBITDA = 7.71 (Net Debt 365.7m / EBITDA 47.5m)
Debt / FCF = 3.96 (Net Debt 365.7m / FCF TTM 92.2m)
Total Stockholder Equity = 770.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.47% (Net Income -59.4m / Total Assets 1.74b)
RoE = -7.71% (Net Income TTM -59.4m / Total Stockholder Equity 770.9m)
RoCE = -2.91% (EBIT -36.3m / Capital Employed (Equity 770.9m + L.T.Debt 476.5m))
RoIC = -1.96% (negative operating profit) (NOPAT -24.3m / Invested Capital 1.24b)
WACC = 8.22% (E(1.99b)/V(2.48b) * Re(9.36%) + D(488.2m)/V(2.48b) * Rd(5.33%) * (1-Tc(0.33)))
Discount Rate = 9.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.89 | Cagr: -4.05%
[DCF] Terminal Value 73.10% ; FCFF base≈111.8m ; Y1≈98.0m ; Y5≈79.2m
[DCF] Fair Price = 31.94 (EV 1.27b - Net Debt 365.7m = Equity 905.5m / Shares 28.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -87.67 | EPS CAGR: -16.78% | SUE: 0.42 | # QB: 0
Revenue Correlation: 46.05 | Revenue CAGR: 2.60% | SUE: 1.74 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.70 | Chg30d=-0.70% | Revisions=-20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.66 | Chg30d=-2.24% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=2.64 | Chg30d=-5.71% | Revisions=-14% | GrowthEPS=-0.8% | GrowthRev=+7.0%
EPS next Year (2027-12-31): EPS=3.11 | Chg30d=+4.01% | Revisions=+0% | GrowthEPS=+17.9% | GrowthRev=+0.6%
[Analyst] Revisions Ratio: -20%